Abstract

We recently outlined the treatment of diabetic retinopathy by the xenon-arc photocoagulator and argon laser.1 We now discuss who should be referred for this treatment. About 10% of patients attending a general diabetic clinic have a retinopathy which may need treatment.2 Photocoagulation can reduce the incidence of blindness in over 60% of those patients with proliferative retinopathy or diabetic maculopathy.3

Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call